Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001104659-26-086733

Director gave up 60 shares (to pay taxes)

  • Director acquired 195,211 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Redmile Group, LLC · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2026-07-22 Exercise or conversion : show line 1 in the form +195,211 636,912 I
2026-07-22 Shares withheld for taxes : show line 2 in the form −60 636,852 I

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-07-22 Exercise or conversion : show line 3 in the form Pre-Funded Warrants to Purchase Common Stock −101,089 0 I
2026-07-22 Exercise or conversion : show line 4 in the form Pre-Funded Warrants to Purchase Common Stock −38,735 0 I
2026-07-22 Exercise or conversion : show line 5 in the form Pre-Funded Warrants to Purchase Common Stock −55,387 0 I
Loading xslF345X06/tm2621190-2_4seq1.xml…